How much is your life science company worth?

Understanding how a company valuation is undertaken can make the difference between failure and success in your negotiations. We provide valuation support to entrepreneurs as well as investors with a special focus on Biotech, Pharma and Medtech. Would you like to know how we calculate the value of your company?

Learn More

Negotiating a licensing deal?

What kind of deal-terms can you expect when out-licensing a product? What will you have to pay when in-licensing? We help clients to understand the value of their asset today and in the future when next milestones are reached.

Value your asset

Raising your next financing round?

When speaking to investors, one of the first questions will be what the value of the company is.
We can help to prepare for this and provide a solid basis to support the successful closing of your next investment round.

Get your company valued

Over 25 years of experience

Here is what our clients say

Arno Groenewoud

Idorsia Pharmaceuticals Ltd.

Great valuation partner for biotech companies. I am happy with the performance of your team, good industry knowledge (e.g. development and commercialization of pharma products), good responsiveness and timeline management, flexible attitude, valuation reports and models in line with expectations.

Hyunsun Park

Aprilbio Inc.

I have worked with a different group of people at Venture Valuation to run asset valuation in the last few years. The valuation report was to the point, identifying the area that needs to be improved, and serves as reference during the negotiation process.

CEO

Cube Labs SpA

Extraordinary level of technical expertise; excellent reputation and recognition (with reference to their sector) in the European Life Science Market; solid execution and quick delivery

Jerry Parrott

CEO of Biomarker Strategies

Our experience with Venture Valuation was collegial, even during the occasional differences of perspective, which are inevitable. We found the ultimate valuation to be fair and comprehensive.

Granath Nils

ZKB Asset Management

Venture Valuation helped us to independently value a large number of companies in a structured and reproducible manner, providing transparency and clear basis for decisions. Great team to work with!

Jürg Meier

Former CEO of Novartis Venture Fund

We found that the reports were of excellent quality. We can recommend Venture Valuation to all parties that have a need for valuation. We are considering to request further valuations from Venture Valuation.

Kostas Alevizopoulos

CEO of APIM Therapeutics AS

Professional service, great interaction with the client, delivery of report according to timelines

Edwin Kwon

CFO of Eutilex Co., Ltd.

Straight forward interaction with the Venture Valuation's team.

Urs Hartmann

CEO of Integra Biosciences

Impressed by fast turn around and delivery in time of a complex content case.

Saad Harti

CEO of Legacy Healthcare

In addition to a report which exceeded expectations, the whole process pushed us to review some of the options we initially considered. I strongly recommend the exercise.

Richard Wright

Azione Inc.

Venture Valuations delivered a very complex valuation in 2 weeks time. Their team were very accommodating and took the time to dive deep into the explanation of the valuation with a diverse group. The team's genuine interest and enthusiasm in their work shines through with the product they deliver.

Guy Hélin

CEO of Syngulon

Venture Valuation provides a well-structured, independent opinion on the company's valuation, supported by a detailed report demonstrating their understanding of the company.

Services Offered

Company Valuation

With our extensive biotech, pharma and medtech experience of over two decades, we guide you through the valuation process, tailoring our services carefully to your needs and circumstances.

View Details

Product Valuation

Understanding the product and IP value as well as possible licensing deal structures is a crucial foundation for your company's strategy. We provide you with an independent product valuation report to consider the financial impact and risk/return of your projects.

View Details

Services for Investors

We assist investors with the key aspects of monitoring, reporting and calculating their net asset value and provide fairness opinions as well as arbitrations.

View Details

Partner search

We help Pharma and Biotech companies to find targeted in-licensing opportunities. With our global network, our Biotechgate database and our own Biotechgate Digital Partnering conference, we have powerful tools at hand to find you the right partner.

View Details

Biotechgate BD&L Database

The Biotechgate Business Development Database is a global BD&L platform covering over 65,000 companies including information about their assets, clinical trials, financing rounds, licensing activities and key management.

View Details